Revive Therapeutics Ltd (RVV.CA)

0.485  -0.03 (-4.9%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Revive Therapeutics Ltd

TSX-V:RVV (4/8/2021, 7:37:03 PM)

0.485

-0.03 (-4.9%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap35.12M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Canadian Stock Screener

Find more stocks on the Canadian

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the Canadian

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the Canadian

RVV Daily chart

Company Profile

Revive Therapeutics Ltd manufactures drugs for medical needs. It researches, develops and commercialize novel treatments for serious and unmet medical needs in the medical cannabis and cannabinoid pharmaceuticals markets.

Company Info

Revive Therapeutics Ltd

5 Director Court

Vaughan ON L4L 4S5

P: +1 905 605-5535

CEO: Craig Leon

RVV.CA News

News Image5 years ago - Revive Therapeutics Ltd.Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility
News Image5 years ago - Revive Therapeutics Ltd.Revive Therapeutics Announces Collaboration and Royalty Agreement With Richmond Cannabis Co.
News Image5 years ago - Revive Therapeutics Ltd.Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation
News Image6 years ago - Revive Therapeutics Ltd.Revive Therapeutics Introduces RELICANN™ a New Brand for Hemp-based CBD Wellness and Medical Cannabis Market
News Image6 years ago - Revive Therapeutics Ltd.Revive Therapeutics Provides Corporate Update
News Image6 years ago - Revive Therapeutics Ltd.Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation

RVV.CA Twits

Here you can normally see the latest stock twits on RVV.CA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example